Collaborative Group on Hormonal Factors in Breast Cancer information
The Collaborative Group on Hormonal Factors in Breast Cancer (CGHFBC) is a group of scientific researchers who conduct meta-analyses of the worldwide epidemiological evidence on risk factors for breast cancer in women. It formed in 1992.[1] Their earliest publications were a 1996 meta-analysis of 54 studies on hormonal birth control and breast cancer risk[2] and a 1997 meta-analysis of 51 studies on menopausal hormone therapy and breast cancer risk.[3] One of their recent publications was a 2019 meta-analysis of menopausal hormone therapy and breast cancer risk based on type and timing of therapy.[1] In 2012, the group concluded in a meta-analysis of 117 studies that the incidence of breast cancer was increased by each year younger at menarche and each year older at menopause.[4]
^ abCollaborative Group on Hormonal Factors in Breast Cancer (September 2019). "Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence". Lancet. 394 (10204): 1159–1168. doi:10.1016/S0140-6736(19)31709-X. PMC 6891893. PMID 31474332.
^Collaborative Group on Hormonal Factors in Breast Cancer (June 1996). "Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies" (PDF). Lancet. 347 (9017): 1713–27. doi:10.1016/s0140-6736(96)90806-5. PMID 8656904. S2CID 36136756.
^"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer". The Lancet. 350 (9084): 1047–1059. 1997. doi:10.1016/S0140-6736(97)08233-0. ISSN 0140-6736. S2CID 54389746.
^Collaborative Group on Hormonal Factors in Breast Cancer (2012). "Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies". The Lancet Oncology. 13 (11): 1141–1151. doi:10.1016/S1470-2045(12)70425-4. ISSN 1470-2045. PMC 3488186. PMID 23084519.
and 24 Related for: Collaborative Group on Hormonal Factors in Breast Cancer information
The CollaborativeGrouponHormonalFactorsinBreastCancer (CGHFBC) is a group of scientific researchers who conduct meta-analyses of the worldwide epidemiological...
ISSN 1361-259X. CollaborativeGrouponHormonalFactorsinBreastCancer (September 2019). "Type and timing of menopausal hormone therapy and breastcancer risk:...
ovarian cancer". Cancer Research UK. Retrieved 27 March 2023. CollaborativeGrouponHormonalFactorsinBreastCancer (1997). "Breastcancer and hormone replacement...
between alcohol and breastcancer is clear: drinking alcoholic beverages, including wine, beer, or liquor, is a risk factor for breastcancer, as well as some...
D, Vanderhyden BC (March 2008). "Risk factors for ovarian cancer: an overview with emphasis onhormonalfactors". Journal of Toxicology and Environmental...
Collaborative GrouponHormonalFactorsinBreastCancer (June 1996). "Breastcancer and hormonal contraceptives: collaborative reanalysis of individual data on 53...
Cancer symptoms are changes in the body caused by the presence of cancer. They are usually caused by the effect of a canceron the part of the body where...
types of cancerin males are lung cancer, prostate cancer, colorectal cancer, and stomach cancer. In females, the most common types are breastcancer, colorectal...
Factors in BreastCancer, et al. (CollaborativeGrouponHormonalFactorsinBreastCancer) (September 2019). "Type and timing of menopausal hormone therapy...
pus), 10–15% have cancer. Risk factors for endometrial cancer include obesity, insulin resistance and diabetes mellitus, breastcancer, use of tamoxifen...
cytokines or hormones) or the lesions may have common predisposing factors. A very serious type of breastcancer called inflammatory breastcancer presents...
Hormonal contraception refers to birth control methods that act on the endocrine system. Almost all methods are composed of steroid hormones, although...
Growth hormone (GH) or somatotropin, also known as human growth hormone (hGH or HGH) in its human form, is a peptide hormone that stimulates growth, cell...
long-standing diabetes is a known risk factor for pancreatic cancer (see Risk factors), the cancer can itself cause diabetes, in which case recent onset of diabetes...
(December 2011). "Reproductive factors and histologic subtype in relation to mortality after a breastcancer diagnosis". BreastCancer Research and Treatment...
Alcohol and cancer have a complex relationship. Alcohol causes cancers of the oesophagus, liver, breast, colon, oral cavity, rectum, pharynx, and larynx...
in the stool, a change in bowel movements, weight loss, abdominal pain and fatigue. Most colorectal cancers are due to old age and lifestyle factors,...
cancer cells. Research oncancer vaccines is underway for treatment of breast, lung, colon, skin, kidney, prostate and other cancers. Another approach is...
number of other hematologic malignancies. The hormonal contribution to several categories of breastcancer subtypes was recognized during this time[when...
Williams and Wilkins. p. 848. ISBN 978-0-7817-9516-6. Early BreastCancer Trialists' CollaborativeGroup (EBCTCG); Correa, C.; McGale, P.; Taylor, C.; Wang, Y...
Global Information